Anti-angiogenic effects of epigallocatechin-3-gallate in human skin

Study Design
Subject Type
Human
Trial Design
Double-Blind, Randomised, Controlled
Trial Duration
42 days
Participants
4
Age Range
40-59 years
Efficacy
Intervention(s) Outcome
Skin Redness
Sign in to read for free
Mechanisms
Intervention(s) Outcome
Blood Vessels
Sign in to read for free
Vascular Endothelial Growth Factor
Sign in to read for free
Study Summary
Sign in to read for free